Wipfli Financial Advisors Llc, Genmab A/S Transaction History
Wipfli Financial Advisors Llc,
- $1.42 Billion
- Q3 2022
A detailed history of Wipfli Financial Advisors Llc, transactions in Genmab A/S stock. As of the latest transaction made, Wipfli Financial Advisors Llc, holds 5,313 shares of GMAB stock, worth $118,320. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,313Holding current value
$118,320% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding GMAB
# of Institutions
249Shares Held
65.9MCall Options Held
729KPut Options Held
398K-
Alliancebernstein L.P. New York, NY14.7MShares$328 Million0.11% of portfolio
-
Orbis Allan Gray LTD Hamilton, D05.71MShares$127 Million0.8% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$113 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.43MShares$98.6 Million0.02% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.88MShares$64.2 Million0.45% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $14.7B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...